Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Public ClinicalTrials.gov record NCT03189875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS): Prospective Observational Cohort of Patients With Moderate-to-severe SLE to Characterize Cross-sectional and Longitudinal Disease Activity, Treatment Patterns and Effectiveness, Outcomes and Comorbidities, Healthcare Resource Utilization, and the Impact of SLE on Quality of Life by Type I Interferon Expression
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
SPOCS is an international, multicenter, prospective observational cohort study with bi-annual study visits over a 3-year follow-up designed to systematically describe the comprehensive SLE patient-journey regarding clinical features, disease progression and treatment patterns, SLE outcomes, health status assessments (PROs), and health care resource utilization (HCRU) in a general population of moderate-to-severe SLE patients.
Study identification
- NCT ID
- NCT03189875
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 830 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 28, 2017 (Actual)
- Primary completion
- Nov 18, 2022 (Actual)
- Completion
- Nov 18, 2022 (Actual)
- Last update posted
- Feb 28, 2024
2017 – 2022
United States locations
- U.S. sites
- 31
- U.S. states
- 16
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85037 | — |
| Research Site | Tucson | Arizona | 85724 | — |
| Research Site | Jonesboro | Arkansas | 72401 | — |
| Research Site | Beverly Hills | California | 90211 | — |
| Research Site | El Cajon | California | 92020 | — |
| Research Site | Loma Linda | California | 92354 | — |
| Research Site | Los Alamitos | California | 90720-5403 | — |
| Research Site | Los Angeles | California | 90095 | — |
| Research Site | Mission Viejo | California | 92691 | — |
| Research Site | San Francisco | California | 94143 | — |
| Research Site | West Hills | California | 91307 | — |
| Research Site | Miami | Florida | 33126 | — |
| Research Site | Tamarac | Florida | 33321 | — |
| Research Site | Coeur d'Alene | Idaho | 83814 | — |
| Research Site | Chicago | Illinois | 60612 | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | Baltimore | Maryland | 21218 | — |
| Research Site | Baltimore | Maryland | 21286 | — |
| Research Site | Detroit | Michigan | 48202 | — |
| Research Site | Nashua | New Hampshire | 03060 | — |
| Research Site | Newark | New Jersey | 07103 | — |
| Research Site | Great Neck | New York | 11021 | — |
| Research Site | The Bronx | New York | 10461 | — |
| Research Site | Durham | North Carolina | 27710 | — |
| Research Site | Greensboro | North Carolina | 27408 | — |
| Research Site | Salisbury | North Carolina | 28144 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | Pittsburgh | Pennsylvania | 15232 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | The Woodlands | Texas | 77382 | — |
| Research Site | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03189875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2024 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03189875 live on ClinicalTrials.gov.